Auto Added by WPeMatico
Meta’s US$2 billion acquisition of AI agent startup Manus has become every enterprise CTO’s cross-border compliance risk lesson. China’s Ministry of Commerce announced on January 9 that it would assess whether the deal violated export controls, technology transfer rules, and overseas investment regulations, despite Manus relocating from Beijing to Singapore in 2025. The investigation exposes […]
Manufacturing factories are producing more data than they can easily process, and companies like Bosch are turning to AI to close that gap. Cameras watch production lines, sensors track machines, and software records each step of the process. However, much of that information still does not lead to faster decisions or fewer breakdowns. For large
Bosch’s €2.9 billion AI investment and shifting manufacturing priorities Read More »
Agentic AI represents a distinct evolution from stateless chatbots toward complex workflows, and scaling it requires new memory architecture. As foundation models scale toward trillions of parameters and context windows reach millions of tokens, the computational cost of remembering history is rising faster than the ability to process it. Organisations deploying these systems now face
Agentic AI scaling requires new memory architecture Read More »
AI chip shortage became the defining constraint for enterprise AI deployments in 2025, forcing CTOs to confront an uncomfortable reality: semiconductor geopolitics and supply chain physics matter more than software roadmaps or vendor commitments. What began as US export controls restricting advanced AI chips to China evolved into a broader infrastructure crisis affecting enterprises globally—not
2025’s AI chip wars: What enterprise leaders learned about supply chain reality Read More »
For a company built on intellectual property, scale creates a familiar tension. Disney needs to produce and distribute content across many formats and audiences, while keeping tight control over rights, safety, and brand consistency. Generative AI promises speed and flexibility, but unmanaged use risks creating legal, creative, and operational drag. Disney’s agreement with OpenAI shows
Why Disney is embedding generative AI into its operating model Read More »
Under China’s push to clean up its energy system, AI is starting to shape how power is produced, moved, and used — not in abstract policy terms, but in day-to-day operations. In Chifeng, a city in northern China, a renewable-powered factory offers a clear example. The site produces hydrogen and ammonia using electricity generated entirely
Inside China’s push to apply AI across its energy system Read More »
Cognizant, Tata Consultancy Services, Infosys, and Wipro have announced plans to deploy more than 200,000 Microsoft Copilot licenses in their enterprises – over 50,000 per company – in what Microsoft is calling a new benchmark for enterprise-scale adoption of generative AI. The companies involved are framing the move as the implementation of a default tool
50,000 Copilot licences for Indian service companies Read More »
Zara is testing how far generative AI can be pushed into everyday retail operations, starting with a part of the business that rarely gets attention in technology discussions: product imagery. Recent reporting shows the retailer using AI to generate new images of real models wearing different outfits, based on existing photoshoots. Models remain involved in
Zara’s use of AI shows how retail workflows are quietly changing Read More »
By December 2025, AI adoption on Wall Street had moved past experiments inside large US banks and into everyday operations. Speaking at a Goldman Sachs financial-services conference in New York on 9 December, bank executives described AI—particularly generative AI—as an operational upgrade already lifting productivity across engineering, operations, and customer service. The same discussion also
Wall Street’s AI gains are here — banks plan for fewer people Read More »
Big Pharma’s AI race extends across drug discovery, development, and clinical trials—but AstraZeneca has distinguished itself by deploying AI clinical trials technology at an unprecedented public health scale. While competitors optimise internal R&D pipelines, AstraZeneca’s AI is already embedded in national healthcare systems, screening hundreds of thousands of patients and demonstrating what happens when AI
